| Orwin Says Affymax Entering $2 Billion Dialysis Market - Washington Post |
|
|
Washington Post June 27 (Bloomberg) -- John Orwin, chief executive officer of Affymax Inc., talks about the company's efforts to secure FDA approval for its first product, a drug used in the treatment of kidney dialysis patients with anemia. Orwin also discusses drug |